Moriguchi, Japan

Kiyokazu Jimpo


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Kiyokazu Jimpo

Introduction

Kiyokazu Jimpo, a distinguished inventor hailing from Moriguchi, Japan, has made notable contributions to the field of antimicrobial agents. With a strong focus on creating effective solutions for bacterial infections, Jimpo holds a crucial patent that showcases his innovative spirit and dedication to improving public health.

Latest Patents

Jimpo's patent, titled "Antimicrobial 7-(.alpha.-acylamino-.alpha.-arylacetamido)-3-(substituted Compounds of the formula ##STR1##," describes a unique composition of compounds. These novel compounds, where R1 is hydrogen or a (C1-C4) alkyl group, X is a straight or branched chain C1-C4 alkylene group, and R2 is a carboxyl group or a sulfo group, display significant antibacterial properties. Specifically, they effectively inhibit a wide range of Gram-positive and Gram-negative bacteria, including notorious strains such as Pseudomonas aeruginosa, indole-positive Proteus, and Enterobacter aerogenes. Thanks to their particular formulation, these antimicrobial agents not only demonstrate strong inhibitory activity but also maintain elevated serum levels in living organisms, making them a promising option for the treatment of infectious diseases.

Career Highlights

Kiyokazu Jimpo is currently associated with Sumitomo Chemical Company, Limited, a respected organization within the chemical industry. His role at this company has allowed him to focus on research and development, leveraging his skills to create impactful solutions that address pressing health concerns. The success of his patent underscores his expertise and commitment to advancing medical science.

Collaborations

Throughout his career, Jimpo has collaborated with esteemed colleagues, including Hirotada Yamada and Takao Okuda. These partnerships have fostered a collaborative environment, enabling the team to explore innovative approaches and enhance the effectiveness of their research outcomes, ultimately leading to significant advancements in antimicrobial therapies.

Conclusion

Kiyokazu Jimpo's dedication to developing effective antimicrobial agents represents the spirit of innovation that drives progress in healthcare. His patented work not only highlights his inventive capabilities but also emphasizes the importance of collaboration in achieving groundbreaking scientific discoveries. Kiyokazu Jimpo continues to be a noteworthy figure in the realm of pharmaceuticals, paving the way for future inventions that will aid in the fight against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…